Cargando…
Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common tumor across the globe with a high mortality rate. ZSCAN20 is a ZNF transcription factor, a key determinant of gene expression. Nonetheless, the mechanism of ZSCAN20 as a potential clinical biomarker and therapeutic target for HCC is not understood. Here, T...
Autores principales: | Jiayu, Fang, Jiang, Yike, Zhou, Xuanrui, Zhou, Minqin, Pan, Jingying, Ke, Yun, Zhen, Jing, Huang, Da, Jiang, Weifan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792207/ https://www.ncbi.nlm.nih.gov/pubmed/36462500 http://dx.doi.org/10.18632/aging.204312 |
Ejemplares similares
-
Correction for: Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2023) -
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023) -
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
por: Gong, Yiyang, et al.
Publicado: (2023) -
ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
por: Zhen, Jing, et al.
Publicado: (2022) -
Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
por: Ding, Yongqi, et al.
Publicado: (2023)